ResMed Inc. will attend the World Sleep Congress in Singapore from September 5-10, 2025. At this event, ResMed will launch the Sleep Institute, a global clinical insights initiative aimed at advancing the understanding of sleep health. The Sleep Institute will debut with a symposium addressing the global underdiagnosis of obstructive sleep apnea (OSA) and will explore barriers in diagnostic pathways, offering scalable solutions to improve access and outcomes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9522837-en) on September 03, 2025, and is solely responsible for the information contained therein.